Using an Innovative N-of-1 Trial Approach Testing Efficacy of Salt Supplementation in Gitelman Syndrome

被引：0
|
作者：
Verploegen, Maartje F. [1 ]
Wieers, Michiel L. [2 ]
Giardina, Federica [3 ]
Trepiccione, Francesco [4 ]
Walsh, Stephen B. [5 ]
Hoorn, Ewout J. [2 ]
Nijenhuis, Tom [1 ]
机构：
[1] Radboudumc Afdeling Nierziekten, Nijmegen, Netherlands
[2] Erasmus MC Afdeling Inwendige Geneeskunde, Rotterdam, Netherlands
[3] Radboudumc Dept Hlth Evidence, Nijmegen, Netherlands
[4] Univ Campania Luigi Vanvitelli, Dipartimento Sci Med Traslaz, Naples, Italy
[5] UCL, Dept Renal Med, London, England
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
FR-PO337
引用
收藏
页码：416 / 416
页数：1
相关论文
共 34 条
  • [31] Exploring Symptom Fluctuations and Triggers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Novel Patient-Centred N-of-1 Observational Designs: A Protocol for a Feasibility and Acceptability Study (Aug, 10.1007/s40271-.021-.00540-0, 2021)
    McDonald, Suzanne
    Tan, Samuel X.
    Banu, Shamima
    van Driel, Mieke
    McGree, James M.
    Mitchell, Geoffrey
    Nikles, Jane
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2022, 15 (02): : 267 - 267
  • [32] Efficacy and safety of hepcidin-based screen-and-treat approaches using two different doses versus a standard universal approach of iron supplementation in young children in rural Gambia: a double-blind randomised controlled trial
    Rita Wegmüller
    Amat Bah
    Lindsay Kendall
    Morgan M. Goheen
    Sarah Mulwa
    Carla Cerami
    Diego Moretti
    Andrew M. Prentice
    BMC Pediatrics, 16
  • [33] Efficacy and safety of hepcidin-based screen-and-treat approaches using two different doses versus a standard universal approach of iron supplementation in young children in rural Gambia: a double-blind randomised controlled trial
    Wegmuller, Rita
    Bah, Amat
    Kendall, Lindsay
    Goheen, Morgan M.
    Mulwa, Sarah
    Cerami, Carla
    Moretti, Diego
    Prentice, Andrew M.
    BMC PEDIATRICS, 2016, 16
  • [34] INnoVative trial design for testing the Efficacy, Safety and Tolerability of 6-month treatment with incretin-based therapy to prevent type 1 DIAbetes in autoantibody positive participants: A protocol for three parallel double-blind, randomised controlled trials (INVESTDIA)
    Kero, Jukka
    Koskenniemi, Jaakko J.
    Karsikas, Sara
    Pokka, Tytti
    Lou, Olivia
    Toppari, Jorma
    Veijola, Riitta
    DIABETIC MEDICINE, 2022, 39 (10)
1234